Navigation Links
OraSure HIV-1 Oral Specimen Collection Device

ProductsOraSure HIV-1 Oral Specimen Collection Device
Company OraSure Technologies, Inc.
Item OraSure HIV-1 Oral Specimen Collection Device
Features Some applications may include:
  • Protecting ER staff by identifying HIV-positive patients prior to treatment
  • Identifying exposure to HIV through accidental needle sticks
  • Minimizing HIV transmission to the infant of an infected mother during childbirth
  • Ensuring that HIV-positive inmates are identified upon internment
Description Testing with an OraSure HIV-1 Oral Specimen Collection Device is a safe, easy, and reliable way to test for HIV-1 antibodies. Testing with the OraSure HIV-1 Oral Specimen Collection Device requires no blood or needles and has been shown to be more than 99% accurate.

OraSure HIV-1 uses a specially treated cotton fiber pad attached to a nylon stick which is placed between the lower cheek and gum and left for 2-5 minutes. The OraSure HIV-1 collection pad draws IgG antibodies out of the tissues of the cheek and gum. This sample, called oral mucosal transudate, contains far fewer contaminants than typically found in saliva. If present, antibodies to the HIV-1 virus will be collected in this sample.

The pad is then placed in the OraSure HIV-1 transport vial. This vial contains preservative which will keep the sample stable for up to 21 days at 39 F to 98 F. The sample is then sent off to a qualified OraSure HIV-1 testing laboratory for analysis using the OraSure HIV-1 testing algorithm .

The tests performed at the laboratory test for antibodies to the HIV-1 virus, not the virus itself. This is why OraSure HIV-1 can test for HIV-1, but the virus is not known to be transmittable through oral fluids.

Info OraSure Technologies, Inc.
Customer Service: (610) 882-1820
Web site: http://www.orasure.com

Related medicine products :

1. OraSure HIV-1 Western Blo
2. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
3. Reveal Rapid HIV-1 Antibody Test
4. Vironostika HIV-1 Plus O Microelisa System
5. Genetic Systems HIV-1/HIV-2 Peptide EIA
6. AMPLICOR HIV-1 Monitor Test, v1.5
7. ViroSeq HIV-1 Genotyping System
8. Procleix HIV-1/HCV Assay
9. NucliSens HIV-1 QT
10. Genetic Systems HIV-1 Western Blot
11. Cambridge Biotech HIV-1 (Western Blot)
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products:
(Date:5/12/2008)...ses Association charged with illegally attaining p...cuses for unsolicited mailers to,workers, CORAL... California,Nurses Association (CNA) violated Iowa...ials to 2,000 nurses represented by the Service Em...ding to a lawsuit filed on behalf,of nurses today....
(Date:5/12/2008)...e effects, loss of effectiveness over time , ...s that are widely used to treat restless legs synd...ide effects and a gradual loss of effectiveness th...w analysis finds. , "One of the things that we ...e more robust effects early in therapy," said stud...
(Date:5/12/2008)...y 12 /PRNewswire-USNewswire/ -- Most baby boomers ...l disability, according to a,new survey conducted ...h,Insurance Plans (AHIP). Baby boomers would have ... into their retirement savings if a disability,occ...prnh/20040830/AHIPLOGO ), "Baby boomers have t...
(Date:5/12/2008)...sments worldwide verify safety and quality of tech... material., DENVER, May 12 /PRNewswire/ -- C5 Med...s for the medical device industry, has submitted a...nd Drug Administration (FDA) for,its new technical...cks.,ZirDent(TM) is a zirconium material ideally s...
Breaking Medicine News(10 mins):Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 3Health News:Drugs for Restless Legs Syndrome Have Downsides 2Health News:Drugs for Restless Legs Syndrome Have Downsides 3Health News:Most Baby Boomers are Financially Unprepared for a Potential Disability 2Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2
...ed the world's first artificial stomach that may a...help develop healthier// foods to manipulate the d...am and colleagues at Norwich's Institute of Food R...orrosive gut acids and enzymes, and can be fed rea...
...ours and gives its yellow colour to Indian curries...matoid arthritis// and osteoporosis, says a US stu...ies by practitioners of Ayurvedic medicine in Indi...orders. Turmeric extract containing the ingredien...
...ho are known for their entrepreneurial skills and ... the trade of buying tribal girls// for their inhe...al problem in the country. One of the main reason...d ratio in the community is the traditional dowry ...
...receive treatment by way of radiation or surgery w...iod, does not impact longevity when compared// to ...rter duration, a recent study has revealed. "Many...er are treated with two or more years of hormone t...
Other Medicine News:Health News:British scientists create artificial stomach 2Health News:Turmeric prevents rheumatoid arthritis: US study 2Health News:Even 6 months or more of hormone therapy treatment does not impact longevity of prostate cancer patients 2
(Date:5/12/2008)...ike a radio dial, not an on/off,light switch; a di...evelop,late in life, MEMPHIS, Tenn., May 12 /PR...arch Hospital study shows that T cells, the body,s...f switches to govern the cellular,machinery that r...hey,possess sophisticated molecular controls that ...
(Date:5/12/2008)...irstCall/ -- Arbios Systems, Inc.,(OTC Bulletin Bo...ceived,approval from the U.S. Food and Drug Admini...ption ("IDE") to begin the pivotal clinical,trial ... body) liver assist,device for blood purification ...er disease., "We are pleased to have received FDA...
(Date:5/12/2008)... Improvement in T-Cell Responses Further S... DIEGO, May 12 /- Nventa Bi...unced positive immunological data from the,third c... lead product,candidate, HspE7, in patients with c...rsor to cervical cancer. HPV 16 E7-specific T-cell...
(Date:5/9/2008)...swire/ -- Many strong acting pain,medications have... and,vomiting with short-term use, and constipatio... patients to discontinue treatment, adding additio...s. The novel investigational,medication tapentadol...,relief for patients with fewer gastrointestinal s...
Breaking Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Patients perceived cancer care unaffected by lower Medicare reimbursements 3071 1Patients perceived cancer care unaffected by lower Medicare reimbursements 3071 2More Damage Than Good 3F Shock Survey Reveals Sport can Actually be bad for Your Joints 3067 1More Damage Than Good 3F Shock Survey Reveals Sport can Actually be bad for Your Joints 3067 2More Damage Than Good 3F Shock Survey Reveals Sport can Actually be bad for Your Joints 3067 3Great disappointment in veto of SCHIP legislation expressed by American College of Physicians 3063 1Great disappointment in veto of SCHIP legislation expressed by American College of Physicians 3063 2Heart Healthy Workouts Help Knees Too 3059 1Heart Healthy Workouts Help Knees Too 3059 2
...ORNE, N.Y.--(BUSINESS WIRE)--Apr 25, 2007 - Acorda...ced that Dr.,Lauren Krupp, Professor of Neurology ...Acorda,s Phase 3 clinical trial of,Fampridine-SR i...,reception on May 2, 2007. This reception will fol...ademy of Neurology (AAN) annual,meeting., Dr. Krup...
...NHAGEN, Denmark; April 25, 2007 - Genmab A/S (CSE:...II study with,ofatumumab (HuMax-CD20™) in pa...cepted for oral presentation at the 2007,Annual Eu...presentation, which will include new results from ...y with ofatumumab, along with data,from the previo...
Other Medicine Technology:Acorda Therapeutics to Host Analyst and Investor Reception 2